WebPurpose: Chemotherapy-induced peripheral neuropathy (CIPN) with associated chronic pain is a common and disabling condition. Current treatments for neuropathic pain in CIPN are … WebFeb 11, 2024 · Chemotherapy-induced peripheral neuropathy (CIPN) is a primary dose-limiting side effect caused by antineoplastic agents, such as paclitaxel. A primary …
Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel …
WebThrough a combination of bioluminescent imaging, behavioral, biochemical, and immunohistochemical approaches, we investigated the role of SCS and paclitaxel (PTX) on tumor growth and PTX-induced peripheral neuropathy (PIPN) pain development in T-cell–deficient male rats (Crl:NIH-Foxn1 rnu) with xenograft human non–small cell lung … WebMar 30, 2024 · In a paclitaxel-induced peripheral neuropathic pain rat model, paclitaxel treatment resulted in elevated expression of NLRP3, caspase-1, and IL-1β in dorsal root ganglion (DRG) and sciatic nerve . The expression of NLRP3 was primarily expressed in macrophages that infiltrated in DRG and sciatic nerve (Table 1). s2cities
Full article: TRPV1 is involved in the antinociceptive effects of ...
WebPaclitaxel-induced peripheral neuropathy (PIPN) and associated neuropathic pain are the most common and serious adverse effects experienced by cancer patients receiving paclitaxel treatment. These effects adversely impact daily activities and consequently the quality of life, sometimes forcing the suspension of treatment and negatively ... WebFeb 11, 2024 · ICOS agonist antibody (ICOSaa) promotes the resolution of mechanical hypersensitivity in paclitaxel-induced peripheral neuropathic pain. A The cohorts of mice were subjected to intraperitoneal injection of 4 mg/kg paclitaxel every other day for a cumulative dosage of 16 mg/kg according to the schema shown followed by intrathecal … WebNov 3, 2024 · Therefore, the search for novel drugs is crucial to obtain treatments that effectively suppress neuropathic pain. The present study was undertaken to investigate the antinociceptive properties of (1,4-bis-(diphenylphosphino) butane) palladium (II) chloride monohydrate (Compound 1) in a paclitaxel (PTX)-induced neuropathic pain model. s2c660